Boditech Med

Boditech Med FCF per Share

The Free Cash Flow per Share of Boditech Med (206640.KQ) as of Nov 3, 2026 is -549.97 KRW. In the previous year, Free Cash Flow per Share was 564.74 KRW — a change of -197.38% (lower).

FCF per Share

-549.97KRW

YoY

-197.38%

Last updated:

Free Cash Flow per Share of Boditech Med is 2025 -549.97 KRW. Free Cash Flow per Share of Boditech Med was 2024 564.74 KRW. It decreases by -197.38% lower compared to the previous year.

The Boditech Med FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
74.58 KRW
Jan 1, 2019
547.06 KRW
Jan 1, 2020
1,760.44 KRW
Jan 1, 2021
1,403.12 KRW
Jan 1, 2022
355.43 KRW
Jan 1, 2023
1,305.01 KRW
Jan 1, 2024
564.74 KRW
Jan 1, 2025
-549.97 KRW
The Boditech Med FCF per Share history
YEARFCF per ShareYoY
-549.97KRW-197.38%
564.74KRW-56.72%
1,305.01KRW+267.17%
355.43KRW-74.67%
1,403.12KRW-20.30%
1,760.44KRW+221.80%
547.06KRW+633.54%
74.58KRW-133.69%
-221.39KRW-359.53%
85.30KRW+574.06%
12.65KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boditech Med Stock analysis

What does Boditech Med do? Boditech Med, Inc. generates revenue through the manufacture and sale of in-vitro diagnostics analyzers and reagents, including antigen diagnostic kits, cancer diagnostic kits, and drug concentration diagnostic kits. The company serves domestic and overseas markets with its products, focusing on diagnostic solutions for healthcare providers and laboratories. Its product portfolio targets medical professionals seeking reliable testing tools for disease detection and treatment monitoring. The firm's primary customers are healthcare institutions and diagnostic laboratories that require specialized testing equipment and consumables. By offering a range of diagnostic kits for various medical applications, Boditech Med addresses the needs of both local and international clients in the healthcare sector. The company's products are designed to support clinical decision-making through accurate and efficient diagnostic processes. Boditech Med is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boditech Med stock

Free Cash Flow per Share of Boditech Med is -549.97 KRW in 2025.

Free Cash Flow per Share of Boditech Med changed from 564.74 KRW to -549.97 KRW, representing a -197.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Boditech Med since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Boditech Med

All Key Metrics — Boditech Med